INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. - URGN
Provided By PR Newswire
Last update: May 21, 2025
NEW YORK, May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of UroGen Pharma Ltd. ("UroGen" or the "Company") (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.com4.24
+0.27 (+6.8%)
Find more stocks in the Stock Screener
URGN Latest News and Analysis
17 days ago - ChartmillLet's have a look at the top gainers and losers one hour before the close of the markets of today's session.Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
17 days ago - ChartmillTop stock movements in today's session.Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
17 days ago - ChartmillThe market is filled with gapping stocks in Friday's session.The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
